Type 2 Diabetes Remission and Control in Overweight and in Mildly Obese Diabetic Patients at Long-Term Follow-Up After Biliopancreatic Diversion

Background In severely obese patients with type 2 diabetes (T2DM), the metabolic benefits after biliopancreatic diversion (BPD) are due to mechanisms independent of weight loss. Therefore, the anti-diabetic effect of BPD in overweight or mildly obese T2DM patients was investigated. Methods Ninety T2...

Full description

Saved in:
Bibliographic Details
Published in:Obesity surgery 2019-01, Vol.29 (1), p.239-245
Main Authors: Adami, Gian Franco, Camerini, Giovanni, Papadia, Francesco, Catalano, Maria Francesca, Carlini, Flavia, Cordera, Renzo, Scopinaro, Nicola
Format: Article
Language:English
Subjects:
Adult
Biliopancreatic Diversion - statistics & numerical data
Blood Glucose - metabolism
Diabetes
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - metabolism
Diabetes Mellitus, Type 2 - surgery
Female
Follow-Up Studies
Glucose
Glycated Hemoglobin A - metabolism
Humans
Hypoglycemic Agents - therapeutic use
Insulin - metabolism
Insulin resistance
Insulin Resistance - physiology
Insulin-Secreting Cells - metabolism
Male
Medicine
Medicine & Public Health
Metabolism
Middle Aged
Obesity
Obesity - complications
Obesity - metabolism
Obesity - pathology
Obesity - surgery
Original Contributions
Overweight - complications
Overweight - metabolism
Overweight - surgery
Remission Induction
Severity of Illness Index
Surgery
Weight Loss - physiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background In severely obese patients with type 2 diabetes (T2DM), the metabolic benefits after biliopancreatic diversion (BPD) are due to mechanisms independent of weight loss. Therefore, the anti-diabetic effect of BPD in overweight or mildly obese T2DM patients was investigated. Methods Ninety T2DM patients with BMI 25–35 underwent BPD and were evaluated 1 and 5 years after the operation (follow-up rate 100 and 83%, respectively). Results T2DM control (Hb1Ac
ISSN:0960-8923
1708-0428
DOI:10.1007/s11695-018-3511-6